Th 2-Skewing Adjuvant Administration of an Emulsome-Based Regulatory T Cells and Is Enhanced by + Is Associated with Induction of LAP Attenuates Collagen-Induced Arthritis That Mucosal Anti-CD 3 Monoclonal Antibody

[1]  H. Weiner,et al.  Oral tolerance , 2011, Immunological reviews.

[2]  Yaron Ilan,et al.  Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice , 2010, Proceedings of the National Academy of Sciences.

[3]  H. Weiner,et al.  Cutting Edge: Human Latency-Associated Peptide+ T Cells: A Novel Regulatory T Cell Subset , 2010, The Journal of Immunology.

[4]  Richard O. Williams,et al.  ANTI-CD3 therapy expands the numbers of CD4+ and CD8+ Treg cells and induces sustained amelioration of collagen-induced arthritis. , 2010, Arthritis and rheumatism.

[5]  K. Hirata,et al.  Oral Anti-CD3 Antibody Treatment Induces Regulatory T Cells and Inhibits the Development of Atherosclerosis in Mice , 2009, Circulation.

[6]  H. Weiner,et al.  Suppression of murine SLE by oral anti-CD3: inducible CD4+CD25-LAP+ regulatory T cells control the expansion of IL-17+ follicular helper T cells , 2009, Lupus.

[7]  H. Wu.  Induction of mucosal tolerance in SLE: a sniff or a sip away from ameliorating lupus? , 2009, Clinical immunology.

[8]  H. Weiner,et al.  Oral Administration of OKT3 Monoclonal Antibody to Human Subjects Induces a Dose-Dependent Immunologic Effect in T Cells and Dendritic Cells , 2009, Journal of Clinical Immunology.

[9]  H. Weiner,et al.  Nasal Anti-CD3 Antibody Ameliorates Lupus by Inducing an IL-10-Secreting CD4+CD25−LAP+ Regulatory T Cell and Is Associated with Down-Regulation of IL-17+CD4+ICOS+CXCR5+ Follicular Helper T Cells1 , 2008, The Journal of Immunology.

[10]  W. van Eden,et al.  Oral or Nasal Antigen Induces Regulatory T Cells That Suppress Arthritis and Proliferation of Arthritogenic T Cells in Joint Draining Lymph Nodes , 2008, The Journal of Immunology.

[11]  L. Bressollette.  Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. , 2008 .

[12]  H. Weiner,et al.  Inhibition of Autoimmune Diabetes by Oral Administration of Anti-CD3 Monoclonal Antibody , 2007, Diabetes.

[13]  L. Chatenoud.  Immune therapies of autoimmune diseases: are we approaching a real cure? , 2006, Current opinion in immunology.

[14]  H. Weiner,et al.  Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+CD25−LAP+ T cells , 2006, Nature Medicine.

[15]  H. Weiner,et al.  The mechanism of nasal tolerance in lupus prone mice is T-cell anergy induced by immature B cells that lack B7 expression. , 2006, Journal of autoimmunity.

[16]  B. Bisikirska,et al.  TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. , 2005, The Journal of clinical investigation.

[17]  M. Moskowitz,et al.  Nasal Vaccination with Myelin Oligodendrocyte Glycoprotein Reduces Stroke Size by Inducing IL-10-Producing CD4+ T Cells1 , 2003, The Journal of Immunology.

[18]  N. Staines,et al.  Histone Peptide-Induced Nasal Tolerance: Suppression of Murine Lupus1 , 2002, The Journal of Immunology.

[19]  T. Nichterlein,et al.  Efficient treatment of murine systemic infection with Candida albicans using amphotericin B incorporated in nanosize range particles (emulsomes) , 2001, Mycoses.

[20]  H. Weiner,et al.  Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen. , 1999, Journal of autoimmunity.

[21]  H. Etlinger,et al.  the Journal of Immunology , 2006 .

[22]  R. Redfield,et al.  Proteosomes, emulsomes, and cholera toxin B improve nasal immunogenicity of human immunodeficiency virus gp160 in mice: induction of serum, intestinal, vaginal, and lung IgA and IgG. , 1997, The Journal of infectious diseases.

[23]  F. Breedveld,et al.  Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. , 1996, Arthritis and rheumatism.

[24]  Claudia Mauri,et al.  Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen‐induced arthritis , 1996, European journal of immunology.

[25]  L. Chatenoud,et al.  Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[26]  H. Weiner,et al.  Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Kang,et al.  Incidence and specificity of antibodies to types I, II, III, IV, and V collagen in rheumatoid arthritis and other rheumatic diseases as measured by 125I-radioimmunoassay. , 1983, Arthritis and rheumatism.

[28]  A. Kang,et al.  Autoimmunity to type II collagen an experimental model of arthritis , 1977, The Journal of experimental medicine.